OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
Cindy X. Cai, Michelle R. Hribar, Sally L. Baxter, et al.
JAMA Ophthalmology (2025)
Closed Access | Times Cited: 7
Cindy X. Cai, Michelle R. Hribar, Sally L. Baxter, et al.
JAMA Ophthalmology (2025)
Closed Access | Times Cited: 7
Showing 7 citing articles:
Cardiovascular–Endocrine–Metabolic Medicine: Proposing a New Clinical Sub-Specialty Amid the Cardiometabolic Pandemic
Nikolaos Theodorakis, Maria Nikolaou, Andrew J. Krentz
Biomolecules (2025) Vol. 15, Iss. 3, pp. 373-373
Open Access | Times Cited: 1
Nikolaos Theodorakis, Maria Nikolaou, Andrew J. Krentz
Biomolecules (2025) Vol. 15, Iss. 3, pp. 373-373
Open Access | Times Cited: 1
Semaglutide and Risk of NAION—Additional Insights
Joseph F. Rizzo, Jimena Tatiana Hathaway
JAMA Ophthalmology (2025)
Closed Access
Joseph F. Rizzo, Jimena Tatiana Hathaway
JAMA Ophthalmology (2025)
Closed Access
Semaglutide-related optic neuropathy
Reactions Weekly (2025) Vol. 2048, Iss. 1, pp. 11-11
Closed Access
Reactions Weekly (2025) Vol. 2048, Iss. 1, pp. 11-11
Closed Access
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
Angela Procacci, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Obesity Research & Clinical Practice (2025)
Closed Access
Angela Procacci, Elisabetta Poluzzi, Fabrizio De Ponti, et al.
Obesity Research & Clinical Practice (2025)
Closed Access
The OHDSI Network in Ophthalmology—The Promise of Observational Health Data
Michelle R. Hribar, Cindy X. Cai, Kerry Goetz, et al.
JAMA Ophthalmology (2025)
Closed Access
Michelle R. Hribar, Cindy X. Cai, Kerry Goetz, et al.
JAMA Ophthalmology (2025)
Closed Access
Conflicting Results—Need for More Transparent and Reproducible Research
Cindy X. Cai, Michelle R. Hribar, Akihiko Nishimura
JAMA Ophthalmology (2025)
Closed Access
Cindy X. Cai, Michelle R. Hribar, Akihiko Nishimura
JAMA Ophthalmology (2025)
Closed Access
Non arteritic ischemic optic neuropathy in a patient taking semaglutide: Is there a relation? A case report and a review of the literature
Martina Maceroni, Paola Sasso, Matteo Giarletti, et al.
European Journal of Ophthalmology (2025)
Closed Access
Martina Maceroni, Paola Sasso, Matteo Giarletti, et al.
European Journal of Ophthalmology (2025)
Closed Access
What the diabetologist needs to know about the risk of non-arteritic anterior ischemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes
S. Feldman–Billard
Diabetes & Metabolism (2025), pp. 101664-101664
Closed Access
S. Feldman–Billard
Diabetes & Metabolism (2025), pp. 101664-101664
Closed Access
Nonarteritic anterior ischemic optic neuropathy and glucagon-like peptide-1 receptor agonists: Evaluating a potential association
Laşin Özbek, Mustafa Güldan, D Fidan, et al.
European Journal of Internal Medicine (2025)
Closed Access
Laşin Özbek, Mustafa Güldan, D Fidan, et al.
European Journal of Internal Medicine (2025)
Closed Access
